AIRMAX™ vs. Breathe Right® Clinical Study Results

Clinical Study Details

• The Safronov clinical trial showed a better efficacy of AIRMAX™ Breathe Right® in terms of reduction in air resistance in the nose
• The total resistance was measured on 24 patients and showed a higher efficacy for the AIRMAX™
• The overall reduction in air resistance (vs. no usage of any nasal dilator) is 3.6 times higher with the AIRMAX™

Clinical Study Source

Non-invasive modality of snoring treatment and OSAS prophylactics (K. Vogt, K. Perksis, Y. Safronov). The effect of the device was tested by 4 phase Rhinomanometry as well by VAS (visual analog scale) in healthy subjects during normal and accelerated breathing.